Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026)
Zymeworks' (ZYME) quarterly Change in Acquisitions & Divestments came in at $70.2 million in Q1 2026, up 50.75% year-on-year from $46.6 million in Q1 2025, and up 11.54% quarter-over-quarter from $62.9 million in Q4 2025.
Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Zymeworks has disclosed Change in Acquisitions & Divestments across 5 years of filings, most recently posting $70.2 million for Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $70.2 million, up 50.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $248.7 million (down 20.36% YoY), and the FY2025 annual result was $225.1 million, down 30.87% from the prior year.
- Change in Acquisitions & Divestments came in at $70.2 million for Q1 2026 at Zymeworks, up from $62.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $125.9 million in Q3 2024 to a low of -$46.2 million in Q4 2022.
- The 5-year median for Change in Acquisitions & Divestments is $62.3 million (2023), against an average of $64.5 million.
- Across the five-year window, Change in Acquisitions & Divestments surged 234.96% in 2023 and sank 71.55% in 2025, its largest moves.
- Zymeworks' Change in Acquisitions & Divestments stood at -$46.2 million in 2022, then soared by 234.96% to $62.3 million in 2023, then retreated by 23.11% to $47.9 million in 2024, then surged by 31.29% to $62.9 million in 2025, then rose by 11.54% to $70.2 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $70.2 million (Q1 2026), $62.9 million (Q4 2025), and $35.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.18 Mn |
| Mar 31, 2026 | 70.18 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Sep 30, 2025 | 35.83 Mn |
| Sep 30, 2025 | 35.83 Mn |
| Jun 30, 2025 | 79.78 Mn |
| Jun 30, 2025 | 79.78 Mn |
| Mar 31, 2025 | 46.55 Mn |
| Mar 31, 2025 | 46.55 Mn |
| Dec 31, 2024 | 47.92 Mn |
| Dec 31, 2024 | 47.92 Mn |
| Sep 30, 2024 | 125.95 Mn |
| Sep 30, 2024 | 125.95 Mn |
| Jun 30, 2024 | 91.85 Mn |
| Jun 30, 2024 | 91.85 Mn |
| Mar 31, 2024 | 59.85 Mn |
| Mar 31, 2024 | 59.85 Mn |
| Dec 31, 2023 | 62.33 Mn |
| Dec 31, 2023 | 62.33 Mn |